We are live on ! Find out more
SRDX

Surmodics

Delisted

SRDX was delisted on the 18th of November, 2025.

116 hedge funds and large institutions have $424M invested in Surmodics in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 32 increasing their positions, 41 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $658K

36% more capital invested

Capital invested by funds: $311M → $424M (+$113M)

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

1% more funds holding

Funds holding: 115116 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.28% less ownership

Funds ownership: 84.76%84.48% (-0.28%)

22% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 41

Holders
116
Holders Change
+1
Holders Change %
+0.87%
% of All Funds
2.65%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
32
Reduced
41
Closed
9
Calls
$1.29M
Puts
$658K
Net Calls
+$628K
Net Calls Change
-$977K

SRDX Hedge Fund Activity: Q1 2018 in Review

116 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2018, worth a combined $424M — up 36% from $311M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new SRDX positions and 9 closed out — a net gain of 3 holders — while 32 added to existing stakes and 41 trimmed.

The largest buyer was Trigran Investments, adding an estimated $1.98M. The largest seller was Wellington Management Group, cutting an estimated $1.93M.

  • 116 institutional investors held Surmodics (SRDX) as of Q1 2018, up from 115 in Q4 2017.
  • Funds reported $424M of Surmodics stock for Q1 2018, up 36% quarter-over-quarter.
  • 12 funds opened new Surmodics positions in Q1 2018 and 9 closed out, a net change of +3 holders.
  • The largest Surmodics buyer in Q1 2018 was Trigran Investments, an estimated $1.98M added.
  • The largest Surmodics seller in Q1 2018 was Wellington Management Group, an estimated $1.93M sold.

Based on aggregated 13F filings for Q1 2018.